Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
about
Differential expression of centrosomal proteins at different stages of human gliomaA murine model of targeted infusion for intracranial tumors.Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant gliomamiRNA expression profiling in migrating glioblastoma cells: regulation of cell migration and invasion by miR-23b via targeting of Pyk2.Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes.Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity.Tetraspanin 8-rictor-integrin α3 complex is required for glioma cell migration.A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy.microRNA-153 Targets mTORC2 Component Rictor to Inhibit Glioma CellsGSK621 Targets Glioma Cells via Activating AMP-Activated Protein Kinase SignalingsGab3 overexpression in human glioma mediates Akt activation and tumor cell proliferation.Network and pathway analysis of microRNAs, transcription factors, target genes and host genes in human glioma.The bright and the dark sides of DNA repair in stem cells.Modulating autophagy: a strategy for cancer therapyIntra-arterial chemotherapy for malignant gliomas: a critical analysis.New Trends in Cancer Therapy: Targeting Ion Channels and Transporters.microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cellsRadiation-induced upregulation of telomerase activity escapes PI3-kinase inhibition in two malignant glioma cell lines.Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr.The role of ion channels in the hypoxia-induced aggressiveness of glioblastoma.G protein-coupled receptor kinase 6 is overexpressed in glioma and promotes glioma cell proliferation.The Candidate Tumor Suppressor Gene SLC8A2 Inhibits Invasion, Angiogenesis and Growth of Glioblastoma.Tumor suppressor microRNA‑613 inhibits glioma cell proliferation, invasion and angiogenesis by targeting vascular endothelial growth factor A.Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype.
P2860
Q33597161-19A8172A-3F90-4C2C-814C-EA4F3AF8A664Q33848111-CB65B2DD-75D4-4C71-BB4B-3782C11797F4Q33930115-03926DB7-4D7E-4349-85DA-D372E3289A4FQ34321677-79D7BCC7-5C6D-41F3-8D30-651D575FCEDFQ34722511-72C0DA21-DE9C-4465-A02C-CF3F2281DDC5Q35111750-F2BB5D7D-1EFE-492A-8460-A5BE250CEA2DQ35381006-BDBE7B92-387A-4F7B-A0E5-54F903F846F8Q35677134-785C80CB-A365-42FE-B5AD-C2FF38098712Q36050424-98B723AA-153C-47A1-9894-A586B5508905Q36105554-EC970E7A-8EEB-4F06-8318-42B3253384D4Q36307539-9F9EDD58-CC70-4677-855B-C175A36F6EEAQ36825579-2F43BCB5-7835-4139-A055-281F22991B21Q37731956-73DC2037-1E67-4652-969D-CE4A97DEAB45Q37940741-BA8860C7-546C-49A5-B7D5-77410EC5A374Q37946674-9DCC46F0-A665-4373-B1DF-C6ECD7F0DE58Q38974256-4838A489-1D15-4556-9718-61FBEF25DC38Q39136340-2DB52993-0379-4E2C-BE77-5A77312B9D7BQ39144903-2C81EE3F-8B41-44DF-B70C-581DA046348AQ39352683-9C66029A-6601-4693-8E74-7704E4970011Q41495146-DC75D367-7F65-41DD-84C0-E3EFA5285F56Q41552766-F9850A1F-A579-4142-8B99-24BBFBDECD7CQ47139087-E6CEC5A0-4A51-48BD-A17B-73E3FF5FC971Q47811914-65CD1B4C-10F0-49F5-8AE9-328C1C504DB2Q52776751-3FFC01A9-BABB-4819-B986-AC2D637EBBA7
P2860
Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
@en
Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
@nl
type
label
Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
@en
Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
@nl
prefLabel
Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
@en
Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
@nl
P2093
P1476
Present and potential future adjuvant issues in high-grade astrocytic glioma treatment
@en
P2093
P356
10.1007/978-3-211-78741-0_1
P577
2009-01-01T00:00:00Z